Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

Condition:   Hemophilia A Intervention:   Other: assessment of joint health and bone density Sponsors:   Bloodworks;   Genentech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials